Biocellular-Cellular Regenerative Treatment Scaring Alopecia and Alopecia Areata
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ken Williams, DO
IIMSC
Principal Investigator - Robert W Alexander, MD
GARM-USA
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Kenneth Williams, Do
Irvine, California, United States
Ryan Welter, MD, PhDRecruiting - Regeneris Medical
North Attleboro, Massachusetts, United States
Glenn C Terry, MDRobert W Alexander, MDRyan JP Welter, MD,PhDRecruiting - Regenevita Llc
Stevensville, Montana, United States
Glenn C Terry, MDKen Williams, DOLawrence Samuels, MDMarco Barusco, MDRobert Niedbalski, DORobert W Alexander, MDRyan Welter, MD, PhDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 17 Feb 2017
- Primary completion
- 22 Jan 2025
- Completion
- 22 Jun 2025
- Last update posted
- 16 Apr 2020
- Registered enrollment
- 60
- Registry id
- NCT03078686
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.